OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance
Julia M. Flynn, Sarah N. Zvornicanin, Tenzin Tsepal, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1174-1184
Closed Access | Times Cited: 7
Julia M. Flynn, Sarah N. Zvornicanin, Tenzin Tsepal, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1174-1184
Closed Access | Times Cited: 7
Showing 7 citing articles:
SARS-CoV-2 Drug Resistance and Therapeutic Approaches
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41980-e41980
Open Access | Times Cited: 3
Exploring Possible Drug-Resistant Variants of SARS-CoV-2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
Jessica R. Kenneson, Christina Papini, Su Tang, et al.
ACS Bio & Med Chem Au (2025)
Open Access
Jessica R. Kenneson, Christina Papini, Su Tang, et al.
ACS Bio & Med Chem Au (2025)
Open Access
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic Preparedness
David T. Barkan, Keira Garland, Lei Zhang, et al.
Journal of Medicinal Chemistry (2024)
Open Access | Times Cited: 1
David T. Barkan, Keira Garland, Lei Zhang, et al.
Journal of Medicinal Chemistry (2024)
Open Access | Times Cited: 1
Effects of SARS-CoV-2 Main Protease Mutations at Positions L50, E166, and L167 Rendering Resistance to Covalent and Noncovalent Inhibitors
Andrey Kovalevsky, Annie Aniana, Rodolfo Ghirlando, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 20, pp. 18478-18490
Closed Access | Times Cited: 1
Andrey Kovalevsky, Annie Aniana, Rodolfo Ghirlando, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 20, pp. 18478-18490
Closed Access | Times Cited: 1
Revealing SARS-CoV-2 Mpro Mutation Cold and Hot Spots: Dynamic Residue Network Analysis Meets Machine Learning
Victor Barozi, Shrestha Chakraborty, S. Govender, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3800-3816
Open Access | Times Cited: 1
Victor Barozi, Shrestha Chakraborty, S. Govender, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3800-3816
Open Access | Times Cited: 1
Identification of positions in Human Aldolase A that are neutral for apparent KM
Liskin Swint‐Kruse, Tyler A. Martin, Tiffany Wu, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110183-110183
Open Access
Liskin Swint‐Kruse, Tyler A. Martin, Tiffany Wu, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110183-110183
Open Access
Backstage Heroes—Yeast in COVID-19 Research
Wojciech Grabiński, Andonis Karachitos, Anna Kicińska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12661-12661
Open Access
Wojciech Grabiński, Andonis Karachitos, Anna Kicińska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12661-12661
Open Access
